MedTrace Logo

HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University

NCT01339416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8202

Last updated 2014-04-21

Study results available
· View outcomes & findings →

Summary

Human Immunodeficiency Virus (HIV) infected patients in the HIV registries of Johns Hopkins University, University of North Carolina and Vanderbilt University will be followed in the routine clinical care to estimate the rates of prespecified clinical events in this population.

Conditions

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • ViiV Healthcare

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-05-31
Completion
2013-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339416 on ClinicalTrials.gov